[1] 佟静,王颖,王炳元. 乙醇对肠黏膜屏障功能的影响及作用机制. 山西医药杂志,2012,41（7）:667-669.
[2] 佟静,王颖,王炳元. ML-7对酒精致肠黏膜屏障功能障碍的作用. 中国现代医学杂,2013,23（17）:17-20.
[3] Bajaj JS,Heuman DM,Hylemon PB,et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol,2014,60（5）:940-947.
[4] Chen P,Starkel P,Turner JR,et al. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology,2015,61（3）:883-894.
[5] Yan AW,Fouts DE,Brandl J,et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology,2011,53（1）:96-105.
[6] Hartmann P,Seebauer CT,Schnabl B．Alcoholic liver disease: The gut microbiome and liver cross talk．Alcoholism. Clin Exp Res,2015,39（5）:763-775．
[7] Bajaj JS,Heuman DM,Hylemon PB,et al. Randomised clinical trial:Lactobacillus GG modulates gut microbiome,metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther,2014,39（10）:1113-1125.
[8] Bajaj JS,Cox IJ,Betrapally NS,et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. Am J Physiol Gastrointest Liver Physiol,2014,307（10）:G951-957.
[9] Bajaj JS,Heuman DM,Sanyal AJ,et al. Modulation of the meta-
biome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One,2013,8（4）:e60042
[10] Xu J,Lai KKY,Verlinsky A,et al. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol,2011,55（3）:673-682.
[11] Tian C,Stokowski RP,Kershenobich D,et al. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet,2010,42（1）:21-23.
[12] Goodrich JK,Waters JL,Poole AC,Set al. Human genetics shape the gut microbiome. Cell,2014,159（4）:789-799.
[13] Gupta A,Dhiman RK,Kumari S,et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol,2010,53（5）:849-855.
[14] 徐贝贝,李银玲,王炳元. ALD相关危险因素的研究进展. 中华肝脏病杂志,2017,25（5）:397-400.
[15] Shindo K,Machida M,Miyakawa K,et al. A syndrome of cirrhosis,achlorhydria,small intestinal bacterial overgrowth,and fat malabsorption. Am J Gastroenterol,1993,88（12）:2084-2091.
[16] Kakiyama G,Hylemon PB,Zhou H,et al. Colonic inflammation and secondary bile acids in alcoholic cirrhosis. Am J Physiol Gastrointest Liver Physiol,2014,306（11）:G929-937.
[17] Inagaki T,Moschetta A,Lee YK,et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci USA,2006,103（10）:3920-3925.
[18] Wang L,Fouts DE,Starkel P,et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe,2016,19（2）:227-239.
[19] 王炳元. 重症酒精性肝炎需要关注的几个问题. 实用肝脏病杂志,2014,17（1）:3-4.
[20] Han SH,Suk KT,Kim DJ,et al. Effects of probiotics （cultured Lactobacillus subtilis/Streptococcus faecium） in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur J Gastroenterol Hepatol,2015,27（11）:1300-1306.
[21] Mookerjee RP,Stadlbauer V,Lidder S,et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology,2007,46（3）:831-840.
[22] Tang Y,Forsyth CB,Banan A,et al. Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage. J Pharmacol Exp Ther,2009,329（3）:952-958.
[23] Moratalla A,Ampuero J,Bellot P,et al. Lactulose reduces bacterial DNA translocation,which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver Int,2017,37（2）:212-223.
[24] Madrid AM,Hurtado C,Venegas M,et al. Long-term treatment with cisapride and antibiotics in liver cirrhosis:effect on small intestinal motility,bacterial overgrowth,and liver function. Am J Gastroenterol,2001,96（4）:1251-1255. |
